169 related articles for article (PubMed ID: 21725080)
1. Radiation dose management in CT, SPECT/CT and PET/CT techniques.
Mattsson S; Söderberg M
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):13-21. PubMed ID: 21725080
[TBL] [Abstract][Full Text] [Related]
2. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
3. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
Leide-Svegborn S
Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
[TBL] [Abstract][Full Text] [Related]
4. Radiation safety with positron emission tomography and computed tomography.
Devine CE; Mawlawi O
Semin Ultrasound CT MR; 2010 Feb; 31(1):39-45. PubMed ID: 20102694
[TBL] [Abstract][Full Text] [Related]
5. Technological advances in hybrid imaging and impact on dose.
Mattsson S; Andersson M; Söderberg M
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):410-5. PubMed ID: 25802466
[TBL] [Abstract][Full Text] [Related]
6. PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager.
Gelfand MJ; Lemen LC
Semin Nucl Med; 2007 Sep; 37(5):391-8. PubMed ID: 17707244
[TBL] [Abstract][Full Text] [Related]
7. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
8. Occupational per-patient radiation dose from a conservative protocol for veterinary (18) F-fluorodeoxyglucose positron emission tomography.
Martinez NE; Kraft SL; Gibbons DS; Arceneaux BK; Stewart JA; Mama KR; Johnson TE
Vet Radiol Ultrasound; 2012; 53(5):591-7. PubMed ID: 22703227
[TBL] [Abstract][Full Text] [Related]
9. Dose reduction in pediatric hybrid and planar imaging.
Gelfand MJ
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):379-88. PubMed ID: 20823806
[TBL] [Abstract][Full Text] [Related]
10. The determination of patient dose from (18)F-FDG PET/CT examination.
Khamwan K; Krisanachinda A; Pasawang P
Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
[TBL] [Abstract][Full Text] [Related]
11. Personal radiation doses in PET/CT facility: measurements vs. calculations.
Hippeläinen E; Nikkinen P; Ihalainen T; Uusi-Simola J; Savolainen S
Radiat Prot Dosimetry; 2008; 132(1):57-63. PubMed ID: 18713782
[TBL] [Abstract][Full Text] [Related]
12. PET and PET-CT in radiation treatment planning for lung cancer.
Aristei C; Falcinelli L; Palumbo B; Tarducci R
Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
[TBL] [Abstract][Full Text] [Related]
13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
14. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
16. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
Russo AA; Ferrari P; Casale M; Delia R
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292
[TBL] [Abstract][Full Text] [Related]
17. [Clinical use of digital retrospective image fusion of CT, MRI, FDG-PET and SPECT -- fields of indications and results].
Lemke AJ; Niehues SM; Amthauer H; Rohlfing T; Hosten N; Felix R
Rofo; 2004 Dec; 176(12):1811-8. PubMed ID: 15573293
[TBL] [Abstract][Full Text] [Related]
18. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
20. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
